Clinical Trial Update: Effect of Bosentan in Scleroderma Renal Crisis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bosentan for scleroderma renal crisis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma Renal Crisis
• Systemic Sclerosis

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Scleroderma Renal Crisis | Phase 2 | Status: COMPLETED